1DD-LSD
| 1DD-LSD | |
|---|---|
| 1DD-LSD_structure.png | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 123456-78-9 |
| PubChem | 12345678 |
| DrugBank | |
| ChemSpider | 123456 |
| KEGG | |
1DD-LSD is a psychedelic compound that is structurally related to lysergic acid diethylamide (LSD). It belongs to the class of lysergamides, which are known for their potent effects on the serotonin receptor system in the brain.
Chemical Structure and Properties[edit]
1DD-LSD is a derivative of LSD, with a chemical structure that includes a diethylamide group attached to the lysergic acid moiety. The compound is characterized by the presence of a methyl group at the 7-position of the indole ring, which distinguishes it from other lysergamides. The molecular formula of 1DD-LSD is C21H27N3O, and it has a molar mass of 337.46 g/mol.
Pharmacology[edit]
1DD-LSD acts primarily as an agonist at the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects. Like other lysergamides, it may also interact with other serotonin receptor subtypes, as well as dopamine and norepinephrine receptors, contributing to its complex pharmacological profile.
Effects[edit]
The effects of 1DD-LSD are similar to those of LSD, including alterations in perception, mood, and cognition. Users may experience visual and auditory hallucinations, changes in thought patterns, and an altered sense of time. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.
Legal Status[edit]
The legal status of 1DD-LSD varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to LSD and its potential for abuse. In other regions, it may not be specifically scheduled, although it could still be subject to analogue laws.
Synthesis[edit]
The synthesis of 1DD-LSD involves the modification of the lysergic acid backbone, typically starting from ergot alkaloids or synthetic precursors. The process requires advanced knowledge of organic chemistry and access to specialized reagents and equipment.
Related Compounds[edit]
1DD-LSD is part of a broader family of lysergamides, which includes other compounds such as 1P-LSD, ALD-52, and ETH-LAD. These compounds share a common core structure but differ in their side chains, leading to variations in their pharmacological effects and potency.
